Caribbean Hospital Becomes Latest SafeTrace Tx(R) User DENVER, Sept. 13 /PRNewswire-FirstCall/ -- Global Med Technologies(R), Inc. (OTC:GLOB) (BULLETIN BOARD: GLOB) today announced that its Wyndgate Technologies(R) division has licensed its Safe Trace Tx(R) software to the Cardiovascular Center of Puerto Rico and the Caribbean (CCPRC) to manage its transfusion service. Terms of the agreement were not disclosed. (Logo: http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO) SafeTrace Tx is a revolutionary software product designed to raise the standard of care for patients, improve safety, reduce waste and increase efficiency in the blood transfusion continuum. With the number of surgeries performed by CCPRC, having an efficient software system to manage transfusions is critical. CCPRC selected the SafeTrace Tx system to interface with their Keane Laboratory Information System because of Wyndgate's solid reputation and the software's ability to enable CCPRC's staff to effectively manage orders and blood product inventory, further enhancing patient care. Will Willman, Wyndgate Technologies' Senior Vice-President of International Business Development, stated, "We are very pleased to be working with Cardiovascular Center of Puerto Rico and the Caribbean, as well as partnering with Keane to provide CCPRC with valuable laboratory solutions. CCPRC, a prestigious hospital, is leading the way in cardiovascular care and providing treatments to many patients with life-threatening conditions in the region." Mr. Willman continued, "SafeTrace Tx will help CCPRC achieve its continuing commitment to provide high quality blood products and transfusion services to the patients served by its hospital network." Gillie McCreath, Keane's National Account Executive, added, "CCPRC selected the Keane Laboratory Information System (LIS) to replace another vendor due to our product's robust functionality and seamless integration with our other Keane applications installed at CCPRC. We recommended Wyndgate to CCPRC because of their ability to work well with Keane's laboratory product, their expertise in this particular market, and their resilient product." About Cardiovascular Center of Puerto Rico and the Caribbean Founded in 1992, the Cardiovascular Center of Puerto Rico and the Caribbean is the only hospital in the region specializing in the diagnosis, treatment and surgery of cardiovascular conditions. It is also the only institution in Puerto Rico that performs cardiovascular surgery on adults and children, including heart transplant procedures. CCPRC, located in Rio Piedras, Puerto Rico, is a hospital with facilities for cardiac catheterization, six operating rooms, clinical laboratories, radiology, non-invasive laboratories, nuclear medicine and a pharmacy. About Keane and Keane's Healthcare Solutions Division (HSD) In business since 1965 and based in the United States, Keane is a global services firm that specializes in enabling transformation of its clients' business and IT functions. The transformation partner of choice for clients across a broad array of industries. Keane's Healthcare Solutions Division (HSD) provides proprietary software and services to hospitals and long-term care facilities throughout the country. Since 1975, Keane's software has been helping clients increase efficiencies, reduce medical errors, meet regulatory requirements, and enhance revenue cycle management. Keane's core healthcare solutions include EZ-Access, Patcom, Keane InSight, and Keane NetSolutions. Information about Keane HSD is available on the Internet at http://www.keane.com/hsd. About Global Med Technologies, Inc. Global Med Technologies(R), Inc. is an international e-Health medical information technology company providing information management software products and services to the healthcare industry. Its Wyndgate Technologies(R) division is a leading supplier of information management systems to U.S. and international blood centers and hospital transfusion centers. Each year, Wyndgate's products and services manage more than eight million blood components, representing over 27% of the U.S. blood supply. Wyndgate's products are also being used in Canada and sub-Saharan Africa, and are being implemented in the Caribbean. Together, the Donor Doc(TM) interactive donor health history questionnaire, SafeTrace(R) donor management system, and the SafeTrace Tx(R) advanced transfusion management system, recently patented, provide Vein-to-Vein(R) tracking from donor collection to patient transfusion. For more information about Global Med's products and services, please call 800-WYNDGATE or visit http://www.globalmedtech.com/, http://www.peoplemed.com/ and http://www.wyndgate.com/. This news release may include statements that constitute forward-looking statements, usually containing the words "believe," "estimate," "project," "expects" or similar expressions. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this news release. http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO http://photoarchive.ap.org/ DATASOURCE: Global Med Technologies(R), Inc. CONTACT: investors, Paul Holm, , or H.L. Lanzet, , both for Global Med Technologies(R), Inc., +1-212-888-4570; or Michael I. Ruxin, M.D. of Global Med Technologies, Inc., +1-303-238-2000 Web site: http://www.globalmedtech.com/ http://www.peoplemed.com/ http://www.wyndgate.com/ http://www.keane.com/hsd

Copyright